Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Identical Antagonist Selectivity of Central and Peripheral Alpha1-Adrenoceptors

P. B. M. W. M. TIMMERMANS, F. KARAMAT ALI, H. Y. KWA, A. M. C. SCHOOP, F. P. SLOTHORST-GRISDIJK and P. A. VAN ZWIETEN
Molecular Pharmacology September 1981, 20 (2) 295-301;
P. B. M. W. M. TIMMERMANS
Department of Pharmacy, Division of Pharmacotherapy, University of Amsterdam, 1018 TV Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. KARAMAT ALI
Department of Pharmacy, Division of Pharmacotherapy, University of Amsterdam, 1018 TV Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Y. KWA
Department of Pharmacy, Division of Pharmacotherapy, University of Amsterdam, 1018 TV Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. M. C. SCHOOP
Department of Pharmacy, Division of Pharmacotherapy, University of Amsterdam, 1018 TV Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. P. SLOTHORST-GRISDIJK
Department of Pharmacy, Division of Pharmacotherapy, University of Amsterdam, 1018 TV Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P. A. VAN ZWIETEN
Department of Pharmacy, Division of Pharmacotherapy, University of Amsterdam, 1018 TV Amsterdam, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The present study was undertaken to test the relationship between binding affinity for alpha1-adrenoceptors and functional antagonism of drug-induced effects mediated by this type of alpha1-receptor sites for alpha-sympatholytic drugs. The radioligand [3H]prazosin was used to identify alpha1-adrenoceptors in rat brain membranes. The specific binding of [3H]prazosin was rapid, reversible, saturable, and of high affinity (KD = 0.21 nM) and involved a single class of binding sites (Bmax = 95 fmoles/mg of protein). A variety of alpha-adrenoceptor blocking drugs inhibited the specific binding of [3H]prazosin (0.2 nM) according to sigmoid displacement curves from which the corresponding log IC50 values were calculated. The binding sites of [3H]prazosin in rat cerebral membranes possessed the characteristics of alpha1-adrenoceptors. Antagonists such as rauwolscine, tolazoline, yohimbine, and piperoxan, known as selective blocking drugs of alpha2-adrenoceptors, were found to be weak competitors. However, 2-[(2',6'-dimethoxyphenoxyethyl)-aminomethyl]-1,4-benzodioxane (WB-4101) and unlabeled prazosin as well as two of its derivatives, 2-[4-(ethoxyethyloxy)-piperidine-1-yl]-4-amino-6,7-dimethoxyquinazoline (UK-18,596) and 2-[4-(2-(1,4-benzodioxoyl))-piperazine-1-yl]-4-amino-6,7-dimethoxyquinazoline (UK-33,274), which have been classified as antagonists preferably occupying alpha1-adrenoceptors, strongly interfered with this binding. The same alpha-adrenolytic drugs were studied with respect to their antagonism of (-)-phenylephrine-induced increases in diastolic pressure mediated via vascular, postsynaptic alpha1-adrenoceptors in pithed, normotensive rats. This antagonism was quantified with the aid of pA2 values. For the alpha-adrenoceptor antagonists studied (n = 21), the pA2 in vivo correlated well with the log 1/IC50 (r2 = 0.86). Similarly, a close relationship was calculated between the binding data and reported pA2 values with respect to the antagonism of alpha1-adrenoceptor-mediated constrictor effects of the rabbit pulmonary artery in vitro (r2 = 0.90). The results demonstrate that the binding affinity in vitro of antagonists for alpha1-adrenoceptors corresponds with their functional antagonism of alpha1-adrenoceptors in vivo and in vitro. Moreover, these findings point to a similarity among peripheral and central alpha1-adrenoceptors.

ACKNOWLEDGMENTS The generous gifts of drugs by Ciba-Geigy, Glaxo, Hoffmann-La Roche, Janssen Pharmaceutica, Organon, Sandoz, Ward Blenkinsop, Wander, Warner, and Wyeth are gratefully acknowledged. The authors are most obliged to Dr. M. J. Davey (Pfizer, Sandwich, Kent, United Kingdom) for providing tritiated and unlabeled prazosin, UK-18,596, and UK-33,274, and to Dr. J. de Boer (University of Amsterdam) for the synthesis of 6-methyl-and 7-chloropiperoxane.

  • Copyright © 1981 by The American Society for Pharmacology and Experimental Therapeutics

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 20, Issue 2
1 Sep 1981
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Identical Antagonist Selectivity of Central and Peripheral Alpha1-Adrenoceptors
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Identical Antagonist Selectivity of Central and Peripheral Alpha1-Adrenoceptors

P. B. M. W. M. TIMMERMANS, F. KARAMAT ALI, H. Y. KWA, A. M. C. SCHOOP, F. P. SLOTHORST-GRISDIJK and P. A. VAN ZWIETEN
Molecular Pharmacology September 1, 1981, 20 (2) 295-301;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Identical Antagonist Selectivity of Central and Peripheral Alpha1-Adrenoceptors

P. B. M. W. M. TIMMERMANS, F. KARAMAT ALI, H. Y. KWA, A. M. C. SCHOOP, F. P. SLOTHORST-GRISDIJK and P. A. VAN ZWIETEN
Molecular Pharmacology September 1, 1981, 20 (2) 295-301;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

Article

  • Therapeutic Effects of FGF23 Antagonists in Hyp Mice
  • TRPV3 and TRPV4 Channels Coassemble into Heterotetramers
  • Secretin Amino-Terminal Structure-Activity Relationships and Complementary Mutagenesis at the Site of Docking to the Secretin Receptor
Show more Article

Articles

  • Therapeutic Effects of FGF23 Antagonists in Hyp Mice
  • TRPV3 and TRPV4 Channels Coassemble into Heterotetramers
  • Secretin Amino-Terminal Structure-Activity Relationships and Complementary Mutagenesis at the Site of Docking to the Secretin Receptor
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics